Therapeutic Goods Order No. 68 - Standard for Plasticized Polyvinyl Chloride (PVC) Blood Bags (23/02/2001)

Overview

The Therapeutic Goods Order No. 68, issued under the Therapeutic Goods Act 1989, addresses the need for establishing standards for plasticized polyvinyl chloride (PVC) blood bags used in the medical field. This legislative instrument, enacted to ensure the safety and efficacy of therapeutic goods, was introduced by Terry Slater, a delegate of the Minister for Health and Aged Care, in consultation with the Therapeutic Goods Committee. The objective of this order is to align with the Australian Standards, specifically AS 3787.1-1997 and AS 3787.2-1997, which outline the general requirements for single-use, sterile PVC packs for human blood. By setting these standards, the order aims to protect public health by ensuring that blood bags meet necessary safety and quality benchmarks. This legislative measure was necessary to fill a gap in the regulation of blood bags, ensuring they are safe for use in medical procedures.

Scope and Application

The Therapeutic Goods Order No. 68 pertains to the standards for plasticized polyvinyl chloride (PVC) blood bags, specifically setting forth the requirements and criteria that these products must meet for compliance under the Therapeutic Goods Act 1989. This legislation applies to all single-use, sterile plasticized PVC blood packs, including both single blood packs and multiple blood pack systems, used for the collection, storage, and transfusion of human blood. The scope of this Act extends to all entities and individuals involved in the manufacture, distribution, and supply of these therapeutic goods within Australia. The application of the Act is nationwide, covering the entire Commonwealth of Australia, ensuring a consistent standard across all states and territories. While the Act sets the primary standards, the specifics and detailed compliance measures may be further defined and regulated through subordinate instruments, which can extend or restrict the application based on evolving scientific and medical insights.

Key Provisions

The Therapeutic Goods Order No. 68, dated 23rd February 2001, specifies the standards for plasticized polyvinyl chloride (PVC) blood bags as outlined in the Australian Standards AS 3787.1-1997 and AS 3787.2-1997. Section 10 of the Therapeutic Goods Act 1989 empowers the delegate of the Minister for Health and Aged Care to issue such orders, following consultation with the Therapeutic Goods Committee. Under this order, single blood packs must comply with AS 3787.1-1997, while multiple blood pack systems must adhere to AS 3787.2-1997. These standards encompass general requirements for sterility, material composition, and usage protocols for blood bags, ensuring they are suitable for human blood storage and transfusion. The Therapeutic Goods Order No. 68 imposes specific obligations on manufacturers, importers, and suppliers of plasticized PVC blood bags. These entities must ensure that their products meet the standards specified in AS 3787.1-1997 for single blood packs and AS 3787.2-1997 for multiple blood pack systems. Compliance with these standards is mandatory to ensure the safety and efficacy of blood bags used in medical procedures. Manufacturers are required to implement quality control measures, while importers and suppliers must verify that the products they handle meet the established standards before distribution. Breach of the standards set forth in Therapeutic Goods Order No. 68 can result in serious legal consequences. Under the Therapeutic Goods Act 1989, individuals or entities that fail to comply with the standards may face criminal charges and penalties. The specific penalties for contravening the Act include fines and imprisonment, though the exact penalties depend on the severity of the breach. Additionally, non-compliance can lead to civil actions for damages and other remedies. The Therapeutic Goods Order No. 68, therefore, serves as a critical regulatory measure to uphold the safety standards for blood bags, ensuring public health and safety are not compromised.